Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegaly

Michael Madsen, Sanne Fisker, Ulla Feldt-Rasmussen, Mikkel Andreassen, Lars Østergaard Kristensen, Hans Ørskov, Jens Otto L. Jørgensen
  • Clinical Endocrinology, June 2013, Wiley
  • DOI: 10.1111/cen.12239

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/cen.12239

The following have contributed to this page: Professor Ulla Feldt-Rasmussen